Mitchell Kapoor's Stock Ratings

HC Wainwright & Co. Analyst

Mitchell Kapoor is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-4.10%

Smart Score

56.9%

Overall Average Return Percentile

28th

Number of Ratings

131
Buy NowGet Alert
05/17/2024CARMBuy Now
CARISMA Therapeutics
$1.41467.38% → $8ReiteratesBuy → BuyGet Alert
05/15/2024KRROBuy Now
Korro Bio
$54.6083.15%$115 → $100MaintainsBuyGet Alert
05/15/2024MGXBuy Now
Metagenomi
$6.4854.32% → $10ReiteratesBuy → BuyGet Alert
05/14/2024LEGNBuy Now
Legend Biotech
$45.4389.3%$87 → $86MaintainsBuyGet Alert
05/14/2024RPHMBuy Now
Reneo Pharmaceuticals
$1.85-18.92% → $1.5ReiteratesNeutral → NeutralGet Alert
05/13/2024TILBuy Now
Instil Bio
$11.9051.26% → $18ReiteratesBuy → BuyGet Alert
05/13/2024NGNEBuy Now
Neurogene
$34.0149.96%$55 → $51MaintainsBuyGet Alert
05/10/2024CARMBuy Now
CARISMA Therapeutics
$1.41467.38%$9 → $8MaintainsBuyGet Alert
05/10/2024IPSCBuy Now
Century Therapeutics
$3.00266.67%$13 → $11MaintainsBuyGet Alert
05/10/2024TYRABuy Now
Tyra Biosciences
$18.7222.86% → $23ReiteratesBuy → BuyGet Alert
05/10/2024RLYBBuy Now
Rallybio
$1.60462.5% → $9ReiteratesBuy → BuyGet Alert
05/09/2024RNACBuy Now
Cartesian Therapeutics
$26.50103.77% → $54ReiteratesBuy → BuyGet Alert
05/09/2024LEGNBuy Now
Legend Biotech
$45.4391.5% → $87ReiteratesBuy → BuyGet Alert
05/09/2024VERVBuy Now
Verve Therapeutics
$5.93152.95% → $15ReiteratesBuy → BuyGet Alert
05/09/2024CTMXBuy Now
CytomX Therapeutics
$1.92——Reiterates → NeutralGet Alert
05/08/2024NGNEBuy Now
Neurogene
$34.0161.72% → $55ReiteratesBuy → BuyGet Alert
05/08/2024HALOBuy Now
Halozyme Therapeutics
$44.9711.19% → $50ReiteratesBuy → BuyGet Alert
05/07/2024LYELBuy Now
Lyell Immunopharma
$2.67124.72% → $6ReiteratesBuy → BuyGet Alert
05/07/2024RANIBuy Now
Rani Therapeutics Hldgs
$5.51135.93%$12 → $13MaintainsBuyGet Alert
05/07/2024HALOBuy Now
Halozyme Therapeutics
$44.9711.19% → $50ReiteratesBuy → BuyGet Alert
05/07/2024MGXBuy Now
Metagenomi
$6.4854.32% → $10Initiates → BuyGet Alert
05/03/2024NGNEBuy Now
Neurogene
$34.0161.72% → $55ReiteratesBuy → BuyGet Alert
04/30/2024HALOBuy Now
Halozyme Therapeutics
$44.9711.19% → $50ReiteratesBuy → BuyGet Alert
04/23/2024RNACBuy Now
Cartesian Therapeutics
$26.50103.77%$54 → $2MaintainsBuyGet Alert
04/23/2024LEGNBuy Now
Legend Biotech
$45.4391.5% → $87ReiteratesBuy → BuyGet Alert
04/17/2024HALOBuy Now
Halozyme Therapeutics
$44.9711.19% → $50ReiteratesBuy → BuyGet Alert
04/16/2024LEGNBuy Now
Legend Biotech
$45.4391.5% → $87ReiteratesBuy → BuyGet Alert
04/02/2024CARMBuy Now
CARISMA Therapeutics
$1.41538.3%$11 → $9MaintainsBuyGet Alert
04/01/2024LEGNBuy Now
Legend Biotech
$45.4391.5% → $87ReiteratesBuy → BuyGet Alert
03/28/2024KRROBuy Now
Korro Bio
$54.60110.62%$100 → $115MaintainsBuyGet Alert

Recent Analyst Stock Rating News

The Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
Expert Ratings For Halozyme Therapeutics
Analyst Ratings For Legend Biotech
9 Analysts Have This To Say About Halozyme Therapeutics
Unveiling 9 Analyst Insights On Legend Biotech
LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
What 4 Analyst Ratings Have To Say About Legend Biotech
Breaking Down Halozyme Therapeutics: 7 Analysts Share Their Views
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free